Total planned funding: $149,924,705
Allocations
Countries/Regions
Ukraine | $149,924,705 |
Organizational Types
NGO | $39,887,072 |
Private Contractor | $35,293,894 |
Unknown | $25,558,653 |
Own Agency | $21,288,655 |
Multi-lateral Agency | $11,275,607 |
University | $7,560,000 |
Implementing Agency | $5,000,000 |
Other USG Agency | $4,060,824 |
Program Areas
Governance and Systems | $58,698,104 |
Treatment | $32,875,007 |
Prevention | $15,972,292 |
Testing | $15,432,591 |
Management and Operations | $14,166,256 |
Care | $12,367,755 |
Budget Codes
OHSS: Health Systems Strengthening | $29,437,721 |
HTXS: Treatment: Adult Treatment | $21,336,836 |
HVSI: Strategic Information | $19,016,769 |
HVCT: Testing: HIV Testing and Counseling | $15,432,591 |
HVMS: Management and Operations | $14,166,256 |
HTXD: Treatment: ARV Drugs | $11,538,171 |
HLAB: Laboratory Infrastructure | $10,243,614 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $7,817,808 |
HVTB: Care: TB/HIV | $7,074,422 |
HVOP: Sexual Prevention: Other Sexual Prevention | $6,249,544 |
HBHC: Care: Adult Care and Support | $3,668,251 |
HMBL: Biomedical Prevention: Blood Safety | $1,778,944 |
HKID: Care: Orphans and Vulnerable Children | $1,625,082 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $125,996 |
PDTX: Treatment: Pediatric Treatment | $0 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $0 |
PDCS: Care: Pediatric Care and Support | $0 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $0 |
Top Partner Programs
Not Available:
$26,263,369
Countries/Regions
Chemonics International:
$20,772,383
Countries/Regions
USG Aggregated Agencies:
$18,439,068
Countries/Regions
Deloitte Consulting Limited:
$10,671,511
Countries/Regions